Interestingly, over 75% of patients with mesothelioma have only P16INK4a deletions, and these patients generally have poor prognoses and shorter survival rates; almost 30% of primary tumors have been reported to have methylated P16INK4a [26,58]. Here, CDKN2A is linked to mesothelioma.